Interleukin-13 inhibition with lebrikizumab-libkz demonstrates efficacy and safety in pediatric patients with moderate to severe atopic dermatitis. Lebrikizumab-libkz significantly improved disease ...

Please provide your email address to receive an email when new articles are posted on . Both methotrexate and cyclosporin showed efficacy in the treatment of atopic dermatitis in children. While ...

Topical anti-inflammatories, including corticosteroids and calcineurin inhibitors, should be applied once to twice daily to active eczema patches; unless specifically instructed. HealthDay News — In a ...

In this video from the American Academy of Dermatology Annual Meeting, Lawrence F. Eichenfield, MD, discusses new treatment ...

WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) cream 1.5% for children as young as two with mild to moderate atopic ...

Conditional recommendations for prevention include moisturizing skin care and avoiding early introduction of food, human milk consumption, and probiotic or vitamin D supplementation. Management ...

Experts discuss the central role of patient education and the strategic use of topical therapies in managing atopic dermatitis (AD), emphasizing the need for clear communication, age-appropriate ...

Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth cohorts from the Environmental Influences on Child Health Outcomes Children’s ...

Pediatric atopic dermatitis was associated with increased risks of learning and memory difficulties, especially in kids with comorbid neurodevelopmental disorders, a cross-sectional study suggested.

The Saint Louis University Division of Pediatric Dermatology is a nationally recognized center of expertise, providing tertiary medical, surgical and investigative dermatology services for children ...

No one should have to suffer from the dry, flaky skin and blisters that are the most common symptoms of eczema, researchers at the Johns Hopkins School of Medicine want Marylanders to know. “Eczema is ...

New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes. As the leading nonprofit, private funder of ...